Jon Dorsey

Director, Health Economics (Canada, UAE, ANZ) at Prolacta Bioscience

Jon Dorsey, MBA, HEOR-C, CHFP, CRCR, CRMC, CSBI has over 25 years of experience in the healthcare industry. Jon began their career at Henry Company in 1993 as a Sales Manager, where they managed 8 representatives in a 10 state territory. In 1998, they moved on to Novartis as a Sales Representative/Manager, where they were able to refine their leadership skills. In 2003, they joined Merck as a Senior A&A Specialty Division Representative/Specialty Manager. During their time at Merck, they achieved regional rankings from 22/27 to 8/27 in the first 9 months and ranked #1/14 regionally and #13/183 nationally. Jon then joined IKARIA, Inc. in 2004 as an Associate Marketing Manager and Senior Critical Care Business Manager. In 2011, they moved on to Advanced BioHealing, Inc. as a Regional Account Manager - Strategic Accounts, where they were awarded the President's Club in 2011. Jon then joined TEI Biosciences Inc. in 2012 as a Regional Manager. In 2015, they joined Vericel Corporation as a National Sales Director - Burn. In 2019, they began working at Onda Consulting Group as a Senior Business Consultant and at Prolacta Bioscience as Director, Health Economics (Canada, UAE, ANZ) and Director, Health Economics, where they were responsible for healthcare economics analysis of neonatal biologic products in the US inpatient hospital environment.

Jon Dorsey, MBA, HEOR-C, CHFP, CRCR, CRMC, CSBI has an extensive education history. Jon obtained a Bachelor of Arts in Political Science and Government from Purdue University in 1991, followed by a Master of Business Administration from Saint Joseph's University - Erivan K. Haub School of Business in 2008. In 2021, they obtained a Certification in HEOR from Harvard Business School Online. Jon also holds five additional certifications from the Healthcare Financial Management Association (HFMA): Certified Specialist Business Intelligence (CSBI) obtained in 2021, Certified Representative Managed Care (CRMC) obtained in 2021, Certified Revenue Cycle Representative (CRCR) obtained in 2019, Certified Healthcare Financial Professional (CHFP) obtained in 2019, and HEOR - Health Economics Outcomes Research obtained in 2021.

Links

Previous companies

Novartis logo
Merck logo